Androgens Modulate Bcl-2 Agonist of Cell Death (BAD) Expression and Function in Breast Cancer Cells

Androgen receptor (AR) expression in estrogen receptor-positive (ER+) breast cancer (BC) correlates with lower tumor grade and a better clinical outcome. Additionally, in normal mammary epithelium or ER+ BC preclinical models, androgens counteract basal/ER-dependent proliferation. Here, we report an...

Descripción completa

Detalles Bibliográficos
Autores principales: Morelli, Catia, Chiodo, Chiara, Nocito, Marta Claudia, Cormace, Alessandro, Catalano, Stefania, Sisci, Diego, Sirianni, Rosa, Casaburi, Ivan, Andò, Sebastiano, Lanzino, Marilena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487823/
https://www.ncbi.nlm.nih.gov/pubmed/37686282
http://dx.doi.org/10.3390/ijms241713464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487823/
https://www.ncbi.nlm.nih.gov/pubmed/37686282
http://dx.doi.org/10.3390/ijms241713464

Ejemplares similares